JP2012509666A5 - - Google Patents

Download PDF

Info

Publication number
JP2012509666A5
JP2012509666A5 JP2011537633A JP2011537633A JP2012509666A5 JP 2012509666 A5 JP2012509666 A5 JP 2012509666A5 JP 2011537633 A JP2011537633 A JP 2011537633A JP 2011537633 A JP2011537633 A JP 2011537633A JP 2012509666 A5 JP2012509666 A5 JP 2012509666A5
Authority
JP
Japan
Prior art keywords
cells
cell
hspc
population
support
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011537633A
Other languages
English (en)
Japanese (ja)
Other versions
JP5726744B2 (ja
JP2012509666A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/065217 external-priority patent/WO2010059876A2/en
Publication of JP2012509666A publication Critical patent/JP2012509666A/ja
Publication of JP2012509666A5 publication Critical patent/JP2012509666A5/ja
Application granted granted Critical
Publication of JP5726744B2 publication Critical patent/JP5726744B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011537633A 2008-11-21 2009-11-19 生体外におけるヒトｂリンパ球産生培養システム Active JP5726744B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19993208P 2008-11-21 2008-11-21
US61/199,932 2008-11-21
PCT/US2009/065217 WO2010059876A2 (en) 2008-11-21 2009-11-19 In vitro human b lymphopoiesis culture system

Publications (3)

Publication Number Publication Date
JP2012509666A JP2012509666A (ja) 2012-04-26
JP2012509666A5 true JP2012509666A5 (https=) 2013-01-10
JP5726744B2 JP5726744B2 (ja) 2015-06-03

Family

ID=42198808

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011537633A Active JP5726744B2 (ja) 2008-11-21 2009-11-19 生体外におけるヒトｂリンパ球産生培養システム

Country Status (4)

Country Link
US (1) US8133727B2 (https=)
EP (1) EP2358868B1 (https=)
JP (1) JP5726744B2 (https=)
WO (1) WO2010059876A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9074223B2 (en) 2010-01-08 2015-07-07 Immusoft Corporation Vectors and methods for transducing B cells
RU2737765C2 (ru) * 2012-05-04 2020-12-02 Пфайзер Инк. Простатоассоциированные антигены и иммунотерапевтические схемы на основе вакцин
MX2015005862A (es) * 2012-11-13 2015-09-10 Genentech Inc Enriquecimiento de plasmablastos especificos de antigeno.
WO2014152832A1 (en) 2013-03-14 2014-09-25 Immusoft Corporation Methods for in vitro memory b cell differentiation and transduction with vsv-g pseudotyped viral vectors
DK3234107T3 (da) 2014-12-19 2022-10-17 Immusoft Corp B-celler til in vivo-levering af terapeutiske midler
CA2981077A1 (en) * 2015-04-03 2016-10-06 Dana-Farber Cancer Institute, Inc. Composition and methods of genome editing of b-cells
US11525119B2 (en) 2016-09-06 2022-12-13 The Children's Medical Center Corporation Immune cells derived from induced pluripotent stem cell
US11793833B2 (en) 2016-12-02 2023-10-24 Juno Therapeutics, Inc. Engineered B cells and related compositions and methods
EP3765601A1 (en) 2018-03-16 2021-01-20 Immusoft Corporation B cells genetically engineered to secrete follistatin and methods of using the same to treat follistatin-related diseases, conditions, disorders and to enhance muscle growth and strength
CN109234232A (zh) * 2018-09-30 2019-01-18 杭州华安单抗生物技术有限公司 兔外周血b细胞的培养体系及培养方法、抗体的制备方法和应用
JP2024516418A (ja) * 2021-04-30 2024-04-15 ステムセル テクノロジーズ カナダ インコーポレイテッド Ｂ系統細胞を分化及び増大させるための組成物及び方法
WO2025106856A1 (en) * 2023-11-15 2025-05-22 Immusoft Corporation Migratory modified differentiated b cells for cancer therapy
WO2025147573A2 (en) 2024-01-05 2025-07-10 Immusoft Corporation Glp-1 expressing modified b cells for the treatment of metabolic disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7939059B2 (en) * 2001-12-10 2011-05-10 California Institute Of Technology Method for the generation of antigen-specific lymphocytes
JP4238138B2 (ja) * 2001-12-22 2009-03-11 ４−アンチボディ アーゲー 遺伝的に修飾された脊椎動物前駆体リンパ球の生成方法及び異種結合タンパク質の産生を目的としたその使用。
EP2021460A4 (en) * 2006-05-11 2010-11-17 Univ Maryland Biotech Inst GENERAL METHOD FOR GENERATING IN VITRO HUMAN ANTIBODY RESPONSES

Similar Documents

Publication Publication Date Title
JP2012509666A5 (https=)
Wang et al. 3D-organoid culture supports differentiation of human CAR+ iPSCs into highly functional CAR T cells
Iriguchi et al. A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy
Zeng et al. Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance
Spanholtz et al. High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy
Aqmasheh et al. Effects of mesenchymal stem cell derivatives on hematopoiesis and hematopoietic stem cells
JP2023516632A5 (https=)
Bagley et al. Extended culture of multipotent hematopoietic progenitors without cytokine augmentation in a novel three-dimensional device
CN102329769B (zh) 一种获得造血干细胞的方法
Lupo et al. Differentiation of natural killer cells from induced pluripotent stem cells under defined, serum-and feeder-free conditions
US20100233130A1 (en) Method and Apparatus for Maintenance and Expansion of Hematopoietic Stem Cells From Mononuclear Cells
JP2007536936A (ja) 幹細胞集団および使用方法
JP7171055B2 (ja) 多能性幹細胞からヘルパーｔ細胞を製造する方法
Shen et al. Single-cell transcriptome of early hematopoiesis guides arterial endothelial-enhanced functional T cell generation from human PSCs
Edgar et al. Multi-objective optimization reveals time-and dose-dependent inflammatory cytokine-mediated regulation of human stem cell derived T-cell development
Zhu et al. Thymopentin enhances the generation of T-cell lineage derived from human embryonic stem cells in vitro
CN118773133B (zh) 一种诱导性nk细胞及其制备方法和应用
Galić et al. Generation of T lineage cells from human embryonic stem cells in a feeder free system
Chotinantakul et al. Wnt1 accelerates an ex vivo expansion of human cord blood CD34+ CD38− cells
Gaudeaux et al. T-Cell Progenitors as a new immunotherapy to bypass hurdles of allogeneic hematopoietic stem cell transplantation
Nakamori et al. Human bone marrow stromal cells simultaneously support B and T/NK lineage development from human haematopoietic progenitors: a principal role for flt3 ligand in lymphopoiesis
WO2021015615A1 (en) Low density cell culture
US20240218328A1 (en) Compositions and methods for differentiating and expanding b lineage cells
JP2024516418A5 (https=)
Hanley et al. Improving clinical outcomes using adoptively transferred immune cells from umbilical cord blood